p44/p42-MAP kinase expression in papillary thyroid carcinomas

Surgery

Volumn 130, Issue 6, 2001, Pages 936-940

  Specht, Michelle C ^a   Barden, Catherine B ^a   Fahey, Thomas J ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN P44;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ANALYSIS; ENZYME INHIBITION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID PAPILLARY CARCINOMA;

EID: 0035659969     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2001.118381a     Document Type: Article

References (17)

1. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation
2. Regulation of transcription by MAP kinase cascades
3. Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors
4. Constitutive activation of mitogen-activated protein (MAP) kinase in human renal cell carcinoma
5. Activation of mitogen-activated protein kinase is necessary but not sufficient for proliferation of human thyroid epithelial cells induced by mutant Ras
6. Ras oncogene activation induces proliferation in normal human thyroid epithelial cells without loss of differentiation
7. The Ras oncogene induces genomic instability in thyroid PCCL3 cells via the MAPK pathway
8. Tyrosine 1062 of RETMEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival
9. Transformation of mammalian cells by constitutively active MAP kinase
10. Hyperexpression of mitogen-activated protein kinase in human breast cancer
11. Down-regulation of mitogen-activated protein kinases in human colon cancers
12. Differential regulation of MAP kinase cascade in human colorectal tumorigenesis
13. High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis
14. Point mutations of ras oncogenes are an early event in thyroid tumorigenesis
15. Perspective on RET proto-oncogene and thyroid cancer
16. The RET proto-oncogene in human cancers
17. Molecular genetics of thyroid tumors and surgical decision-making